Cargando…
Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
Despite global efforts to control tuberculosis (TB) the estimated number of people who developed TB worldwide increased to an all-time record of more than 10 million in 2015. The goal of the World Health Organization (WHO) to reduce the global incidence of TB to less than 100 cases per million by 20...
Autores principales: | Lange, Christoph, Mandalakas, Anna M., Kalsdorf, Barbara, Denkinger, Claudia M., Sester, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pathogens and Immunity
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315027/ https://www.ncbi.nlm.nih.gov/pubmed/28217762 http://dx.doi.org/10.20411/pai.v1i2.173 |
Ejemplares similares
-
Combined Antigen-Specific Interferon-γ and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection
por: Chesov, Dumitru, et al.
Publicado: (2015) -
Analysis of Factors Lowering Sensitivity of Interferon-γ Release Assay for Tuberculosis
por: Hang, Nguyen Thi Le, et al.
Publicado: (2011) -
Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017) -
Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis
por: Ai, Lu, et al.
Publicado: (2019) -
Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area
por: Kim, Jong Keun, et al.
Publicado: (2013)